Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 09 April 2020 |
| Author/s |
author: Nicola Cascavilla Shien Guo Sujith Dhanasiri Paula Rodríguez-Otero Supratik Basu Athanasios Dimopoulos Philippe Moreau Paulo Lucio Katja Weisel Tsvetan Biyukov Larisa Mendeleeva Paul G. Richardson Marek Hus |
| Publication date | April 9, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |